Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma

Denis Cortese, J. H. Kinsey

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Nineteen patients with cancer involing the tracheobronchial tree (a total of 20 carcinomas) have completed at least one course of hematoporphyrin derivative phototherapy administered via the flexible fiberoptic bronchoscope. Seven patients (eight carcinomas) have shown a complete response. In six of these patients (seven carcinomas), there has been no recurrence of tumor at the site of treatment during follow-up ranging from 8 to 31 months. One patient had a complete response lasting 12 months, but subsequently had a local recurrence producing obstruction; this patient died 24 months after the initial hematoporphyrin derivative phototherapy. Eight other patients had less than a complete response and required alternative therapy. Three of these eight patients died, one of metastases and two of airway obstruction and metastases. The four remaining patients died before results of this local therapy could be assessed; two died of metastases and two of hemoptysis. The cancers in patients who had a complete response were less than 3 sq cm in surface area and appeared superficial at bronchoscopy. Therefore, hematoporphyrin derivative phototherapy does have the potential to become an alternative to surgical resection as the primary treatment in carefully selected patients.

Original languageEnglish (US)
Pages (from-to)8-13
Number of pages6
JournalChest
Volume86
Issue number1
StatePublished - 1984
Externally publishedYes

Fingerprint

Hematoporphyrin Derivative
Phototherapy
Bronchogenic Carcinoma
Therapeutics
Neoplasm Metastasis
Carcinoma
Bronchoscopes
Recurrence
Neoplasms
Hemoptysis
Bronchoscopy
Airway Obstruction
Complementary Therapies

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma. / Cortese, Denis; Kinsey, J. H.

In: Chest, Vol. 86, No. 1, 1984, p. 8-13.

Research output: Contribution to journalArticle

@article{76b6b2b6822844a3b0dd4b8532883b1b,
title = "Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma",
abstract = "Nineteen patients with cancer involing the tracheobronchial tree (a total of 20 carcinomas) have completed at least one course of hematoporphyrin derivative phototherapy administered via the flexible fiberoptic bronchoscope. Seven patients (eight carcinomas) have shown a complete response. In six of these patients (seven carcinomas), there has been no recurrence of tumor at the site of treatment during follow-up ranging from 8 to 31 months. One patient had a complete response lasting 12 months, but subsequently had a local recurrence producing obstruction; this patient died 24 months after the initial hematoporphyrin derivative phototherapy. Eight other patients had less than a complete response and required alternative therapy. Three of these eight patients died, one of metastases and two of airway obstruction and metastases. The four remaining patients died before results of this local therapy could be assessed; two died of metastases and two of hemoptysis. The cancers in patients who had a complete response were less than 3 sq cm in surface area and appeared superficial at bronchoscopy. Therefore, hematoporphyrin derivative phototherapy does have the potential to become an alternative to surgical resection as the primary treatment in carefully selected patients.",
author = "Denis Cortese and Kinsey, {J. H.}",
year = "1984",
language = "English (US)",
volume = "86",
pages = "8--13",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1",

}

TY - JOUR

T1 - Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma

AU - Cortese, Denis

AU - Kinsey, J. H.

PY - 1984

Y1 - 1984

N2 - Nineteen patients with cancer involing the tracheobronchial tree (a total of 20 carcinomas) have completed at least one course of hematoporphyrin derivative phototherapy administered via the flexible fiberoptic bronchoscope. Seven patients (eight carcinomas) have shown a complete response. In six of these patients (seven carcinomas), there has been no recurrence of tumor at the site of treatment during follow-up ranging from 8 to 31 months. One patient had a complete response lasting 12 months, but subsequently had a local recurrence producing obstruction; this patient died 24 months after the initial hematoporphyrin derivative phototherapy. Eight other patients had less than a complete response and required alternative therapy. Three of these eight patients died, one of metastases and two of airway obstruction and metastases. The four remaining patients died before results of this local therapy could be assessed; two died of metastases and two of hemoptysis. The cancers in patients who had a complete response were less than 3 sq cm in surface area and appeared superficial at bronchoscopy. Therefore, hematoporphyrin derivative phototherapy does have the potential to become an alternative to surgical resection as the primary treatment in carefully selected patients.

AB - Nineteen patients with cancer involing the tracheobronchial tree (a total of 20 carcinomas) have completed at least one course of hematoporphyrin derivative phototherapy administered via the flexible fiberoptic bronchoscope. Seven patients (eight carcinomas) have shown a complete response. In six of these patients (seven carcinomas), there has been no recurrence of tumor at the site of treatment during follow-up ranging from 8 to 31 months. One patient had a complete response lasting 12 months, but subsequently had a local recurrence producing obstruction; this patient died 24 months after the initial hematoporphyrin derivative phototherapy. Eight other patients had less than a complete response and required alternative therapy. Three of these eight patients died, one of metastases and two of airway obstruction and metastases. The four remaining patients died before results of this local therapy could be assessed; two died of metastases and two of hemoptysis. The cancers in patients who had a complete response were less than 3 sq cm in surface area and appeared superficial at bronchoscopy. Therefore, hematoporphyrin derivative phototherapy does have the potential to become an alternative to surgical resection as the primary treatment in carefully selected patients.

UR - http://www.scopus.com/inward/record.url?scp=0021153369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021153369&partnerID=8YFLogxK

M3 - Article

C2 - 6734298

AN - SCOPUS:0021153369

VL - 86

SP - 8

EP - 13

JO - Chest

JF - Chest

SN - 0012-3692

IS - 1

ER -